Wenlong L. Yu - Publications

Benefits of entecavir therapy in HBV-related hepatocellular carcinoma patients with compensated cirrhosis after hepatectomy: A ten-year retrospective cohort study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: October 24, 2024

Establishment of a Lactylation-Related Gene Signature for Hepatocellular Carcinoma Applying Bulk and Single-Cell RNA Sequencing Analysis.

Journal: International journal of genomics

Published: October 16, 2024

Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution.

Journal: Journal of hematology & oncology

Published: October 07, 2024

The AKR1C1-CYP1B1-cAMP signaling axis controls tumorigenicity and ferroptosis susceptibility of extrahepatic cholangiocarcinoma.

Journal: Cell death and differentiation

Published: June 11, 2024

HBcrAg is associated with prognosis of hepatitis B virus-related hepatocellular carcinoma in patients after hepatectomy undergoing antiviral therapy.

Journal: International journal of cancer

Published: May 23, 2024

Metformin dampens the progression of cholangiofibrosis induced by thioacetamide using deep learning.

Journal: Heliyon

Published: May 22, 2024

Can laparoscopic surgery be the preferred strategy for gallbladder cancer?

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: March 03, 2024

Prognostic analysis and risk assessment based on RNA editing in hepatocellular carcinoma.

Journal: Journal of applied genetics

Published: November 03, 2023

Metformin Increases the Response of Cholangiocarcinoma Cells to Gemcitabine by Suppressing Pyruvate Kinase M2 to Activate Mitochondrial Apoptosis.

Journal: Digestive diseases and sciences

Published: April 16, 2023

Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.

Journal: Frontiers in immunology

Published: August 02, 2022

Long Noncoding RNA XIST Promotes Resistance to Lenvatinib in Hepatocellular Carcinoma Cells via Epigenetic Inhibition of NOD2.

Journal: Journal of oncology

Published: July 01, 2022

The Chemopreventive Role of β-Elemene in Cholangiocarcinoma by Restoring PCDH9 Expression.

Journal: Frontiers in oncology

Published: February 12, 2022